StockData
Airsculpt Technologies, Inc. logo

Airsculpt Technologies, Inc. (AIRS) stock

AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3083% below fair value
$0.65−0.06 (-8.87%)

Close on Nov 19, 2026Market cap $47.17MP/E –Yield –

Airsculpt Technologies free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Airsculpt Technologies's free cash flow for the twelve months ending Jun 30, 2026 was $760.00K. For fiscal 2025 it was $692.00K. The highest annual figure on record is $19.52M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$692.00K–
FY2024Dec 31, 2024-$2.66M-118.9%
FY2023Dec 31, 2023$14.04M+21.8%
FY2022Dec 31, 2022$11.53M-40.9%
FY2021Dec 31, 2021$19.52M+90.1%
FY2020Dec 31, 2020$10.27M+1957.7%
FY2019Dec 31, 2019$499.00K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.47M-131.1%
Q1 FY2026Mar 31, 2026$5.22M–
Q4 FY2025Dec 31, 2025-$2.59M–
Q3 FY2025Sep 30, 2025-$405.00K–
Q2 FY2025Jun 30, 2025$4.72M–
Q1 FY2025Mar 31, 2025-$1.03M-157.3%
Q4 FY2024Dec 31, 2024-$815.00K-126.8%
Q3 FY2024Sep 30, 2024-$3.07M–
Q2 FY2024Jun 30, 2024-$576.00K-105.7%
Q1 FY2024Mar 31, 2024$1.80M-25.0%
Q4 FY2023Dec 31, 2023$3.04M-31.6%
Q3 FY2023Sep 30, 2023-$1.48M–
Q2 FY2023Jun 30, 2023$10.08M+18.1%
Q1 FY2023Mar 31, 2023$2.40M-14.3%
Q4 FY2022Dec 31, 2022$4.45M–
Q3 FY2022Sep 30, 2022-$4.26M-161.3%
Q2 FY2022Jun 30, 2022$8.53M-34.8%
Q1 FY2022Mar 31, 2022$2.81M-63.0%
Q4 FY2021Dec 31, 2021-$8.10M–
Q3 FY2021Sep 30, 2021$6.95M–
Q2 FY2021Jun 30, 2021$13.08M–
Q1 FY2021Mar 31, 2021$7.59M–

More Airsculpt Technologies figures

See a number that looks wrong?